Literature DB >> 15254414

Genetic epidemiology of BRCA1.

Fergus J Couch1.   

Abstract

Since the identification of the BRCA1 gene 10 years ago much has been learned about the role of the BRCA1 protein in cancer development. In particular, genetic and epidemiological approaches have informed about the spectrum of mutations that occur in the gene and the prevalence, penetrance, and phenotype associated with these mutations in various populations. Furthermore, advances have been made in understanding the environmental and genetic modifiers of cancer risk associated with BRCA1 mutations. In this review the current knowledge of the genetic epidemiology of BRCA1 is presented and the issues that still need to be addressed in this field are outlined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254414     DOI: 10.4161/cbt.3.6.840

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  6 in total

Review 1.  Aspirin intake may prevent metastasis in patients with triple-negative breast cancer.

Authors:  Erhan Ararat; Ilyas Sahin; Kadri Altundag
Journal:  Med Oncol       Date:  2010-07-29       Impact factor: 3.064

2.  Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.

Authors:  Satish Sankaran; Lea M Starita; Aaron C Groen; Min Ji Ko; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia.

Authors:  Kristiina Tamboom; Krista Kaasik; Jelena Aršavskaja; Mare Tekkel; Aili Lilleorg; Peeter Padrik; Andres Metspalu; Toomas Veidebaum
Journal:  Hered Cancer Clin Pract       Date:  2010-04-09       Impact factor: 2.857

4.  BRCA1 represses amphiregulin gene expression.

Authors:  Ekaterina P Lamber; Andrew A Horwitz; Jeffrey D Parvin
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

5.  Identifying the effects of BRCA1 mutations on homologous recombination using cells that express endogenous wild-type BRCA1.

Authors:  Jeffrey Parvin; Natsuko Chiba; Derek Ransburgh
Journal:  J Vis Exp       Date:  2011-02-17       Impact factor: 1.355

Review 6.  HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?

Authors:  Giuseppe Nunnari; Johanna A Smith; René Daniel
Journal:  J Exp Clin Cancer Res       Date:  2008-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.